Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
229 patents granted to the 6 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Dr. Reddy's Laboratories Limited’s names, not what it holds today.
Patents granted
229
228 utility, 1 reissue, 1976 to Dec 31, 2025
Granted in 2025
2
Against 2 in 2024 and 1 in 2023
Applications published
371
3 of them in 2025
Names they are printed under
6
its own name, a subsidiary
By yearGrantedApplications published
'11'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals10
Organic fine chemistry7
Biotechnology1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name6 counted
DR. REDDY'S LABORATORIES LIMITED its own name
IN, as the owner printed on each patent. 181 more under the same name are not counted (printed in US, printed in GB)
203 publishedDR. REDDY'S LABORATORIES LIMITED its own name
named as the applicant on its applications, in IN. 9 more under the same name are not counted (printed in US, printed in CH, printed in CN)
156 publishedDr. Reddy's Research Foundation a subsidiary
IN, as the owner printed on each patent
6 publishedPromius Pharma LLC a subsidiary
named as the applicant on its applications, in US
6 publishedPROMIUS PHARMA LLC a subsidiary
US, as the owner printed on each patent
0 publishedDr. Reddy's Laboratories New York, Inc. a subsidiary
US, as the owner printed on each patent
0 publishedNames not counted (1)
DR REDDYS LABORATORIES LTD
Most of its patents print CH; this name counts in IN. 3 granted and 1 published under it are not counted.
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Oct 7, 2025 | 12,433,947 | Stable formulations of therapeutic antibody | Pharmaceuticals | DR. REDDY'S LABORATORIES LIMITED |
| Sep 30, 2025 | 12,428,464 | Stable fusion protein formulation | Pharmaceuticals | DR. REDDY'S LABORATORIES LIMITED |
| Jul 9, 2024 | 12,030,948 | Antibody formulation | Pharmaceuticals | DR. REDDY'S LABORATORIES LIMITED |
| Jul 2, 2024 | 12,024,561 | Stable antibody formulation | Pharmaceuticals | DR. REDDY'S LABORATORIES LIMITED |
| May 2, 2023 | 11,639,391 | Stable liquid pharmaceutical composition | Biotechnology | DR. REDDY'S LABORATORIES LIMITED |
| Jul 19, 2022 | 11,390,583 | Process for preparation of Siponimod, its salts and solid state forms thereof | Organic fine chemistry | DR. REDDY'S LABORATORIES LIMITED |
| Jul 12, 2022 | 11,382,923 | Stable liquid formulations of cyclophosphamide and processes to prepare the same | Pharmaceuticals | DR. REDDY'S LABORATORIES LIMITED |
| Jun 21, 2022 | 11,364,212 | Methods for treating inflammatory skin conditions | Pharmaceuticals | DR. REDDY'S LABORATORIES LIMITED |
| Apr 5, 2022 | 11,292,793 | Solid dispersions of amorphous Lumateperone p-Tosylate | Pharmaceuticals | DR. REDDY'S LABORATORIES LIMITED |
| Dec 7, 2021 | 11,191,740 | Methods for treating inflammatory skin conditions | Pharmaceuticals | DR. REDDY'S LABORATORIES LIMITED |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Nov 20, 2025 | 2025/0353880 | IMPROVED PROCESS FOR THE PREPARATION OF VOCLOSPORIN | Biotechnology | DR. REDDY'S LABORATORIES LIMITED |
| Aug 14, 2025 | 2025/0255804 | LIQUID INJECTABLE COMPOSITIONS OF LURBINECTEDIN | Pharmaceuticals | DR. REDDY'S LABORATORIES LIMITED |
| Aug 7, 2025 | 2025/0250340 | METHOD TO PURIFY AN ANTIBODY COMPOSITION | Biotechnology | DR. REDDY'S LABORATORIES LIMITED |
| Dec 26, 2024 | 2024/0424003 | PHARMACEUTICAL COMPOSITIONS FOR MINOCYCLINE | Pharmaceuticals | DR. REDDY'S LABORATORIES LIMITED |
| Dec 5, 2024 | 2024/0400610 | METHOD TO OBTAIN A PURIFIED ANTIBODY COMPOSITION | Biotechnology | DR. REDDY'S LABORATORIES LIMITED |
| Nov 28, 2024 | 2024/0392006 | FORMULATIONS OF IMMUNE CHECK POINT INHIBITORS | Pharmaceuticals | DR. REDDY'S LABORATORIES LIMITED |
| Nov 14, 2024 | 2024/0376211 | A PROCESS TO PRODUCE A PHARMACEUTICAL COMPOSITION | Biotechnology | DR. REDDY'S LABORATORIES LIMITED |
| Nov 14, 2024 | 2024/0376209 | Method To Control High Molecular Weight Aggregates In An Antibody Composition | Biotechnology | DR. REDDY'S LABORATORIES LIMITED |
| Nov 7, 2024 | 2024/0368284 | A METHOD OF IMPROVING STABILITY OF IMMUNE CHECK POINT INHIBITORS | Pharmaceuticals | DR. REDDY'S LABORATORIES LIMITED |
| Nov 7, 2024 | 2024/0366757 | FORMULATIONS OF IMMUNE CHECK POINT INHIBITORS OR LIKE | Pharmaceuticals | DR. REDDY'S LABORATORIES LIMITED |
What it applied for, 2024 to 2025: Pharmaceuticals 12 · Biotechnology 9 · Measurement 1.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.